June 3, 2026
Goldenrod Therapeutics
Goldenrod Therapeutics develops a small molecule to
- Round
- Seed
- Amount raised
- $3.2M
- Lead investor
- —
- Industry
- Biotechnology
- Headquarters
- Houston, United States
- Employees
- 1-10
- Website
- goldenrodtx.com
- —
June 3, 2026
Goldenrod Therapeutics develops a small molecule to